Over-expression of the c-myc proto-oncogene in colorectal carcinoma
- PMID: 8347498
- PMCID: PMC1968538
- DOI: 10.1038/bjc.1993.350
Over-expression of the c-myc proto-oncogene in colorectal carcinoma
Abstract
Alterations in the c-myc proto-oncogene in colorectal cancer were studied at the level of RNA expression, gene amplification and rearrangements. One hundred cases of colorectal cancer, stratified by Dukes' stage were examined. The level of messenger RNA expression was measured in tumours and matched normal mucosa from the same patient. Between 5 and 400 fold over-expression was found in 66% of tumours. Neither the presence nor the level of over-expression correlated with tumour staging. A significant correlation (P < 0.01) was found between over-expression of c-myc in tumours and the presence of synchronous adenomas elsewhere in the colon. In contrast to other tumours, no rearrangements of the gene were found on Southern analysis of colorectal cancers. Similarly, amplification of the gene was not found in the cancers examined.
Similar articles
-
The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.Oncogene. 1988 Apr;2(4):367-78. Oncogene. 1988. PMID: 3283655
-
c-myc oncogene expression in colorectal cancer.Cancer. 1987 Apr 1;59(7):1289-95. doi: 10.1002/1097-0142(19870401)59:7<1289::aid-cncr2820590710>3.0.co;2-o. Cancer. 1987. PMID: 3545431
-
Overexpression and amplification of c-myc during progression of human colorectal cancer.Oncology. 1996 Nov-Dec;53(6):448-54. doi: 10.1159/000227619. Oncology. 1996. PMID: 8960139
-
The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.Semin Surg Oncol. 1987;3(3):152-8. doi: 10.1002/ssu.2980030305. Semin Surg Oncol. 1987. PMID: 2821605 Review.
-
Gene structure and expression in colorectal cancer.Adv Exp Med Biol. 1993;330:67-75. doi: 10.1007/978-1-4615-2926-2_6. Adv Exp Med Biol. 1993. PMID: 7690179 Review.
Cited by
-
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.Br J Cancer. 2005 Jun 20;92(12):2233-9. doi: 10.1038/sj.bjc.6602631. Br J Cancer. 2005. PMID: 15928669 Free PMC article.
-
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression.Br J Cancer. 1996 Mar;73(5):610-4. doi: 10.1038/bjc.1996.105. Br J Cancer. 1996. PMID: 8605094 Free PMC article.
-
Anti-c-myc RNAi-Based Onconanotherapeutics.Biomedicines. 2020 Dec 15;8(12):612. doi: 10.3390/biomedicines8120612. Biomedicines. 2020. PMID: 33333729 Free PMC article. Review.
-
Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.Biochim Biophys Acta. 2012 Oct;1823(10):1807-14. doi: 10.1016/j.bbamcr.2012.07.004. Epub 2012 Jul 16. Biochim Biophys Acta. 2012. PMID: 22801218 Free PMC article.
-
The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A/4B and affects the stability of CRL4 E3 ligases in colorectal cancer.Int J Biol Sci. 2020 Feb 4;16(6):1071-1085. doi: 10.7150/ijbs.41230. eCollection 2020. Int J Biol Sci. 2020. PMID: 32140074 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources